Detailed information for compound 342020

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 386.664 | Formula: C20H38O3SSi
  • H donors: 1 H acceptors: 2 LogP: 6.3 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCC1=C(O)C(SC1=O)(C)CCCCCCO[Si](C(C)(C)C)(C)C
  • InChi: 1S/C20H38O3SSi/c1-8-13-16-17(21)20(5,24-18(16)22)14-11-9-10-12-15-23-25(6,7)19(2,3)4/h21H,8-15H2,1-7H3
  • InChiKey: UOZNVAAVDGJTLI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus 0.071 0.8146 0.8302
Plasmodium falciparum cysteine repeat modular protein 1 0.0504 0.5576 0.5
Loa Loa (eye worm) PAN domain-containing protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) PAN domain-containing protein 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0134 0.0969 0.0987
Echinococcus granulosus tissue type plasminogen activator 0.0504 0.5576 1
Onchocerca volvulus 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0504 0.5576 0.5683
Onchocerca volvulus 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0134 0.0969 0.0987
Onchocerca volvulus 0.0844 0.9812 1
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0134 0.0969 0.0987
Brugia malayi Trypsin family protein 0.0134 0.0969 0.0987
Onchocerca volvulus 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0134 0.0969 0.0987
Loa Loa (eye worm) hypothetical protein 0.0134 0.0969 0.0987
Onchocerca volvulus 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Brugia malayi hypothetical protein 0.0134 0.0969 0.0987
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Brugia malayi Trypsin family protein 0.0134 0.0969 0.0987
Loa Loa (eye worm) hypothetical protein 0.0504 0.5576 0.5683
Brugia malayi Kringle domain containing protein 0.0504 0.5576 0.5683
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Brugia malayi Trypsin-like protease protein 5 0.0134 0.0969 0.0987
Loa Loa (eye worm) hypothetical protein 0.0844 0.9812 1
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Leishmania major hypothetical protein, conserved 0.0504 0.5576 0.5
Loa Loa (eye worm) hypothetical protein 0.0844 0.9812 1
Loa Loa (eye worm) PAN domain-containing protein 0.0057 0.0013 0.0014
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0504 0.5576 0.5
Loa Loa (eye worm) TK/ROR protein kinase 0.0504 0.5576 0.5683
Loa Loa (eye worm) PAN domain-containing protein 0.0057 0.0013 0.0014
Brugia malayi Protein kinase domain containing protein 0.0504 0.5576 0.5683
Loa Loa (eye worm) hypothetical protein 0.0134 0.0969 0.0987
Onchocerca volvulus 0.0057 0.0013 0.0014
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0844 0.9812 0.9791
Loa Loa (eye worm) trypsin family protein 0.0134 0.0969 0.0987
Onchocerca volvulus 0.0134 0.0969 0.0987
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) PAN domain-containing protein 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Loa Loa (eye worm) hypothetical protein 0.0134 0.0969 0.0987
Brugia malayi Chymotrypsin-like protease CTRL-1 precursor 0.0134 0.0969 0.0987
Brugia malayi Trypsin family protein 0.0134 0.0969 0.0987
Brugia malayi Trypsin family protein 0.0844 0.9812 1
Onchocerca volvulus 0.0057 0.0013 0.0014
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0141 0.1064 0.0106
Onchocerca volvulus 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0057 0.0013 0.0014
Onchocerca volvulus 0.0134 0.0969 0.0987
Toxoplasma gondii kringle domain-containing protein 0.0504 0.5576 1
Trypanosoma cruzi hypothetical protein, conserved 0.0504 0.5576 0.5
Echinococcus multilocularis tissue type plasminogen activator 0.0504 0.5576 1
Loa Loa (eye worm) hypothetical protein 0.0057 0.0013 0.0014
Schistosoma mansoni hypothetical protein 0.0504 0.5576 0.5101
Onchocerca volvulus 0.0134 0.0969 0.0987
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Mycobacterium ulcerans hypothetical protein 0.0134 0.0969 0.5
Onchocerca volvulus 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014
Brugia malayi PAN domain containing protein 0.0057 0.0013 0.0014

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 1 uM Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue ChEMBL. 16161997
IC50 (functional) = 1 uM Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue ChEMBL. 16161997
IC50 (functional) = 2 uM Inhibitory concentration against Trypanosoma brucei rhodesiense STIB 900 upon incubation at 37 degrees C in 5% CO2 for 72 hours ChEMBL. 16161997
IC50 (functional) = 2 uM Inhibitory concentration against Trypanosoma brucei rhodesiense STIB 900 upon incubation at 37 degrees C in 5% CO2 for 72 hours ChEMBL. 16161997
IC50 (functional) = 37 uM In vitro inhibitory concentration against erythrocytic stages of chloroquine and pyrimethamine resistant K1 strain of Plasmodium falciparum ChEMBL. 16161997
IC50 (functional) = 37 uM In vitro inhibitory concentration against erythrocytic stages of chloroquine and pyrimethamine resistant K1 strain of Plasmodium falciparum ChEMBL. 16161997
IC50 (functional) = 150 uM Inhibitory concentration against Trypanosoma cruzi [Tulahuen strain C2C4] in rat skeletal myoblasts upon incubation at 37 degrees C for 4 days in 5% CO2 ChEMBL. 16161997
IC50 (functional) = 150 uM Inhibitory concentration against Trypanosoma cruzi [Tulahuen strain C2C4] in rat skeletal myoblasts upon incubation at 37 degrees C for 4 days in 5% CO2 ChEMBL. 16161997
Inhibition (binding) % Percent inhibition of recombinant Plasmodium falciparum Beta-Ketoacyl-acyl carrier protein synthase III activity (MBP-pfKASIII) expressed in E. coli cells using [1-14C]-acetyl-CoA as radioligand upon incubation at 37 degrees C for 15 minutes with compound dissloved in 2% DMSO at 10 uM; NA = no activity ChEMBL. 16161997
Inhibition (binding) NA 0 % Percent inhibition of recombinant Plasmodium falciparum Beta-Ketoacyl-acyl carrier protein synthase III activity (MBP-pfKASIII) expressed in E. coli cells using [1-14C]-acetyl-CoA as radioligand upon incubation at 37 degrees C for 15 minutes with compound dissloved in 2% DMSO at 10 uM; NA = no activity ChEMBL. 16161997

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Trypanosoma brucei gambiense 16161997
Leishmania donovani ChEMBL23 16161997

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.